Key metrics and charts across all fundamental categories.
Stock price and market valuation
CR trades at $206.57, a 34.9% increase year-over-year. Market capitalization stands at $11.92B, up 35.6% from the prior year. Track CR price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$2.44B in TTM revenue grew 15.1% YoY, reaching $696.40M last quarter. TTM EBITDA of $489.00M on operating income of $100.10M shows growth is flowing through. Net income of $326.60M TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $4.05B in assets and $1.19B in long-term debt, the D/E of 0.6 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 36.5x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 4.9x and P/B of 5.7x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.
Operating efficiency and return metrics
Op. margin of 14.4% is down 3.8% YoY — costs are rising relative to revenue. Net margin at 9.6%. ROE of 15.6% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $-40.20M. The FCF / Net Income ratio of -0.1x shows cash consumption — the business is not yet self-funding. Cash reserves of $355.40M provide financial flexibility. Share count is stable — no dilution or buyback activity.
